The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their crucial role in global healthcare. This move reinforces India’s position as a key provider of affordable generic medicines. Leaders highlight the strategic importance of the bilateral trade relationship, with the exemption offering India a chance to enhance its pharmaceutical sector.
Related Posts
Google may be forced to sell world’s most popular browser
The US Department of Justice is preparing to request that Alphabet, Google’s parent company, sell its Chrome browser. The DOJ argues that Chrome gives Google […]
‘Frivolous doubts’: EC hits out at Congress on Haryana EVMs
The Election Commission refutes Congress’ allegations of compromised electoral processes and EVM misuse in Haryana polls. It asserts that no evidence of wrongdoing exists, chastises […]
‘Wanted to kill Khamenei but …’: Israel reveals how Ayatollah evaded assassination
During the recent conflict, Israeli defence minister Israel Katz revealed that Iran’s Supreme Leader Ayatollah Ali Khamenei was a target for assassination but evaded capture […]